Cargando…

Faecal microbiota transplantation in Clostridioides difficile infection: real-life experience from an academic Italian hospital

BACKGROUND: Faecal microbiota transplantation (FMT) is a reasonable therapeutic option for the treatment of Clostridioides difficile infection (CDI) recurrent and refractory (RCDI) to therapy, but little evidence on the long-term impact of this therapy is currently available in the literature. The a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barberio, Brigida, Facchin, Sonia, Mele, Edoardo, D’Incà, Renata, Sturniolo, Giacomo Carlo, Farinati, Fabio, Zingone, Fabiana, Quagliariello, Andrea, Ghisa, Matteo, Massimi, Davide, Casadei, Cesare, Savarino, Edoardo Vincenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Prospects and Challenges into the Role of Gut Microbiome in Health and Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391433/ https://www.ncbi.nlm.nih.gov/pubmed/32774464 http://dx.doi.org/10.1177/1756284820934315

Ejemplares similares

Mechanisms underpinning the efficacy of faecal microbiota transplantation in treating gastrointestinal disease
por: Segal, Jonathan P., et al.
Publicado: (2020)

Gaps in knowledge and future directions for the use of faecal microbiota transplant in the treatment of inflammatory bowel disease
por: Yalchin, Mehmet, et al.
Publicado: (2019)

Efficacy of teduglutide in a patient with Crohn’s disease and short bowel syndrome on enteral nutrition: let’s start to think out of the box
por: Barberio, Brigida, et al.
Publicado: (2019)

Intestinal permeability and bacterial translocation in patients with liver disease, focusing on alcoholic aetiology: methods of assessment and therapeutic intervention
por: Skinner, Charlotte, et al.
Publicado: (2020)

Impact of microbiome-based interventions on gastrointestinal pathogen colonization in the intensive care unit
por: Choy, Alexa, et al.
Publicado: (2020)

The role of the gut microbiome and exercise in non-alcoholic fatty liver disease
por: Houttu, Veera, et al.
Publicado: (2020)

Interplay of intestinal microbiota and mucosal immunity in inflammatory bowel disease: a relationship of frenemies
por: Chen, Huimin, et al.
Publicado: (2020)

The gut microbiome: an under-recognised contributor to the COVID-19 pandemic?
por: Segal, Jonathan P., et al.
Publicado: (2020)

The role of the gastric bacterial microbiome in gastric cancer: Helicobacter pylori and beyond
por: Schulz, Christian, et al.
Publicado: (2019)

The role of gut mycobiome in health and diseases
por: Zhang, Lin, et al.
Publicado: (2021)

The role of bacterial translocation in sepsis: a new target for therapy
por: Potruch, Assaf, et al.
Publicado: (2022)

Recent insights into the role of microbiome in the pathogenesis of obesity
por: van der Vossen, Eduard W. J., et al.
Publicado: (2022)

Unfavourable intrauterine environment contributes to abnormal gut microbiome and metabolome in twins
por: Yang, Jing, et al.
Publicado: (2022)

Cigarette smoke promotes colorectal cancer through modulation of gut microbiota and related metabolites
por: Bai, Xiaowu, et al.
Publicado: (2022)

Impairment of gut microbial biotin metabolism and host biotin status in severe obesity: effect of biotin and prebiotic supplementation on improved metabolism
por: Belda, Eugeni, et al.
Publicado: (2022)

Infliximab Originator, Infliximab Biosimilar, and Adalimumab Are More Effective in Crohn's Disease Than Ulcerative Colitis: A Real-Life Cohort Study
por: Barberio, Brigida, et al.
Publicado: (2020)

Switching from Infliximab Originator to SB2 Biosimilar in Inflammatory Bowel Diseases: A Multicentric Prospective Real-Life Study
por: Massimi, Davide, et al.
Publicado: (2021)

Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Clostridioides difficile infection
por: Mullish, Benjamin H, et al.
Publicado: (2019)

Medical and gastroenterological education during the COVID-19 outbreak
por: Barberio, Brigida, et al.
Publicado: (2020)

Factors Influencing Disability and Quality of Life during Treatment: A Cross-Sectional Study on IBD Patients
por: Marinelli, Carla, et al.
Publicado: (2019)

Reorganization of the functional gastrointestinal disorders unit during the SARS-CoV-2 outbreak - Practical Recommendations
por: Ghisa, Matteo, et al.
Publicado: (2020)

Serum Levels of PCSK9 Are Increased in Patients With Active Ulcerative Colitis Representing a Potential Biomarker of Disease Activity: A Cross-sectional Study
por: Marinelli, Carla, et al.
Publicado: (2022)

Viewing the human microbiome through three-dimensional glasses: integrating structural and functional studies to better define the properties of myriad carbohydrate-active enzymes
por: Turnbaugh, Peter J., et al.
Publicado: (2010)

The structure of BVU2987 from Bacteroides vulgatus reveals a superfamily of bacterial periplasmic proteins with possible inhibitory function
por: Das, Debanu, et al.
Publicado: (2010)

Structure of BT_3984, a member of the SusD/RagB family of nutrient-binding molecules
por: Bakolitsa, Constantina, et al.
Publicado: (2010)

A conserved fold for fimbrial components revealed by the crystal structure of a putative fimbrial assembly protein (BT1062) from Bacteroides thetaiotaomicron at 2.2 Å resolution
por: Xu, Qingping, et al.
Publicado: (2010)

Structure of Bacteroides thetaiotaomicron BT2081 at 2.05 Å resolution: the first structural representative of a new protein family that may play a role in carbohydrate metabolism
por: Yeh, Andrew P., et al.
Publicado: (2010)

Structure of a membrane-attack complex/perforin (MACPF) family protein from the human gut symbiont Bacteroides thetaiotaomicron
por: Xu, Qingping, et al.
Publicado: (2010)

Incidence comparison of adverse events in patients with inflammatory bowel disease receiving different biologic agents: retrospective long-term evaluation
por: Barberio, Brigida, et al.
Publicado: (2022)

Lack of complications in patients with eosinophilic gastrointestinal diseases during SARS-CoV-2 outbreak
por: Savarino, Edoardo, et al.
Publicado: (2020)

No need of transforming gastroenterology units to covid units at the time of SARS-COV2 infection - a single-center analysis from northern italy
por: Zingone, Fabiana, et al.
Publicado: (2020)

Good efficacy and safety of vedolizumab in Crohn’s disease and ulcerative colitis in a real-world scenario
por: Zingone, Fabiana, et al.
Publicado: (2020)

Bacteriophage transfer during faecal microbiota transplantation in Clostridium difficile infection is associated with treatment outcome
por: Zuo, Tao, et al.
Publicado: (2018)

Adalimumab biosimilars, ABP501 and SB5, are equally effective and safe as adalimumab originator
por: Cingolani, Linda, et al.
Publicado: (2021)

The Lyon Consensus: Does It Differ From the Previous Ones?
por: Ghisa, Matteo, et al.
Publicado: (2020)

A Survey on Nutritional Knowledge in Coeliac Disease Compared to Inflammatory Bowel Diseases Patients and Healthy Subjects
por: Marsilio, Ilaria, et al.
Publicado: (2020)

Perception of the COVID-19 Pandemic Among Patients With Inflammatory Bowel Disease in the Time of Telemedicine: Cross-Sectional Questionnaire Study
por: Zingone, Fabiana, et al.
Publicado: (2020)

Rapid point-of-care anti-infliximab antibodies detection in clinical practice: comparison with ELISA and potential for improving therapeutic drug monitoring in IBD patients
por: Facchin, Sonia, et al.
Publicado: (2021)

Vonoprazan Fumarate for the Treatment of Gastric Ulcers: A Short Review on Emerging Data
por: Marabotto, Elisa, et al.
Publicado: (2020)

Faecal microbiota transplantation: applications and limitations in treating gastrointestinal disorders
por: Sbahi, Hani, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_o2nc7u4pcnm6ot3q6e8edopap8